Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Once again, our agenda is rather modest. We hope to catch up on some reading, hang with a short person or two, and promenade with the official mascot. We will also stop to observe some ancient, but meaningful, rituals. And what about you? This is a fine time to consider a little spring cleaning, or enjoy the great outdoors. You could putter around your castle or try to make that appointment for a vaccine. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

Novavax (NVAX) is delaying signing a contract to supply its Covid-19 vaccine to the European Union because the company is struggling to source some raw materials, according to Reuters. Prolonging the talks with the EU might further complicate vaccination plans, as the bloc had planned to sign a deal early this year for at least 100 million doses of the vaccine, with an option for another 100 million. Novavax has eight manufacturing locations, including the Serum Institute of India, the world’s biggest vaccine maker.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.